MedTrace Logo

The Breathe Well Program for Adults With Asthma

NCT02761837 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14978

Last updated 2023-11-09

No results posted yet for this study

Summary

The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.

Conditions

Interventions

BEHAVIORAL

IVR call/text

For patients under filling their inhaled corticosteroid or overusing B-agonist, the patient is contacted via IVR call or text

BEHAVIORAL

Email

Patients under filling their inhaled corticosteroid or overusing B-agonist, the the patient is contacted via email

Sponsors & Collaborators

  • Kaiser Permanente

    collaborator OTHER

  • National Jewish Health

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02761837 on ClinicalTrials.gov